Tregs exert significant effects on inhibiting the function of IFN-γ-expressing CD4+ Th1 cells and producing the secretion of VEGF through hypoxia-mediated CCL-28, which both strikingly result in a pro-angiogenic tumor microenvironment (72) (Figure 3). Here, CD4 is linked to neoplasm.